文献速递肾移植急性肾损伤慢性肾脏病

间充质基质细胞疗法在肾脏病学中的临床转化

Clinical Translation of Mesenchymal Stromal Cell Therapies in Nephrology.
PubMed 文献 · J Am Soc Nephrol · 2017-11-30

本文综述了培养扩增的间充质基质细胞在肾移植、急性肾损伤和慢性肾脏病中的临床试验数据,讨论了其免疫调节、抗炎和促再生等特性,并指出为确保安全性和有效性需解决的转化问题。

要点

  • 临床前研究显示间充质基质细胞可延长移植物存活、诱导免疫耐受、加速AKI恢复和改善慢性肾病功能。
  • 初步临床试验探索了间充质基质细胞在肾移植、AKI和CKD中的安全性、耐受性和有效性。
  • 需解决关键问题以严格评估间充质基质细胞疗法的安全性和有效性,推动临床转化。

核心结论

  • 间充质基质细胞疗法在肾脏病学中具有临床转化潜力,但需严格评估安全性和有效性。

研究设计与样本

  • 综述了培养扩增的间充质基质细胞在肾移植、AKI和CKD中的临床试验数据。

主要发现

  • 临床前研究显示间充质基质细胞可延长实体器官移植物存活并诱导免疫耐受。
  • 临床前研究显示间充质基质细胞可加速AKI恢复并促进慢性肾病功能改善。
  • 间充质基质细胞的免疫调节、抗炎和促再生特性可能贡献上述效应。

临床怎么用

  • 需关注间充质基质细胞疗法在肾移植、AKI和CKD中的安全性、耐受性和有效性证据。

局限性

  • 需解决相关问题以确保严格评估间充质基质细胞疗法的安全性和有效性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Mesenchymal stromal cells have emerged as potential candidates for cell-based therapies to modulate the immune response in organ transplantation and repair tissues after acute or chronic injury. Preclinical studies have shown convincingly in rodent models that mesenchymal stromal cells can prolong solid organ graft survival and that they can induce immune tolerance, accelerate recovery from AKI, and promote functional improvement in chronic nephropathies. Multiple complex properties of the cells, including immunomodulatory, anti-inflammatory, and proregenerative effects, seem to contribute. The promising preclinical studies have encouraged investigators to explore the safety, tolerability, and efficacy of mesenchymal stromal cell-based therapy in pilot clinical trials, including those for bone marrow and solid organ transplantation, autoimmune diseases, and tissue and organ repair. Here, we review the available data on culture-expanded mesenchymal stromal cells tested in renal transplantation, AKI, and CKD. We also briefly discuss the relevant issues that must be addressed to ensure rigorous assessment of the safety and efficacy of mesenchymal stromal cell therapies to allow the translation of this research into the practice of clinical nephrology.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Perico N, Casiraghi F, Remuzzi G, et al. Clinical Translation of Mesenchymal Stromal Cell Therapies in Nephrology. J Am Soc Nephrol. 2017. PMID: 29191959. doi:10.1681/ASN.2017070781

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。